Introduction
============

Chronic Obstructive Pulmonary Disease (COPD) is a major health problem. In 2005, this pulmonary disease was the fourth cause of mortality in Canada ([@b5-v4n1-art-10.5195-ijt.2012.6083]). It is also estimated that the mortality rate from COPD will continue to grow until it becomes the third mortality cause by 2013 ([@b5-v4n1-art-10.5195-ijt.2012.6083]). This pathology is characterized by a progressive bronchial obstruction associated with airway inflammatory process ([@b22-v4n1-art-10.5195-ijt.2012.6083]; [@b24-v4n1-art-10.5195-ijt.2012.6083]). It causes symptoms such as shortness of breath, cough and abundant production of mucus ([@b12-v4n1-art-10.5195-ijt.2012.6083]), which result in intolerance for effort. It has a major impact on people's daily lives and ability to perform their activities, with disastrous consequences on their quality of life ([@b13-v4n1-art-10.5195-ijt.2012.6083]; [@b22-v4n1-art-10.5195-ijt.2012.6083]).

Pulmonary rehabilitation helps to prevent a downward spiral of deconditioning in patients with COPD, leading to exacerbations, deterioration in quality of life and disability ([@b25-v4n1-art-10.5195-ijt.2012.6083]; [@b26-v4n1-art-10.5195-ijt.2012.6083]; [@b33-v4n1-art-10.5195-ijt.2012.6083]). Pulmonary rehabilitation programs typically comprise exercise training, patient education and sometimes psychological support. In addition, pulmonary rehabilitation decreases health care utilization ([@b6-v4n1-art-10.5195-ijt.2012.6083]). Its efficacy has been documented in controlled clinical trials ([@b21-v4n1-art-10.5195-ijt.2012.6083]; [@b30-v4n1-art-10.5195-ijt.2012.6083]) and meta-analyses ([@b17-v4n1-art-10.5195-ijt.2012.6083]; [@b18-v4n1-art-10.5195-ijt.2012.6083]; [@b19-v4n1-art-10.5195-ijt.2012.6083]) to reduce dyspnea, increase tolerance for exercise and improve health-related quality of life as well as functional status. Unfortunately, pulmonary rehabilitation is greatly underutilized ([@b9-v4n1-art-10.5195-ijt.2012.6083]). In 2005, only an estimated 1% to 2% of the Canadian population with COPD had access to pulmonary rehabilitation services at hospital outpatient clinics or at home ([@b9-v4n1-art-10.5195-ijt.2012.6083]). This clearly shows that these services are not able to serve the needs of patients with COPD ([@b9-v4n1-art-10.5195-ijt.2012.6083]). In this context, the health care system must develop new strategies to increase access to pulmonary rehabilitation services.

As a new way to deliver health care services, telerehabilitation, which is defined as a telehealth application using telecommunication technologies to dispense rehabilitation services, is a new approach in the rehabilitation domain that allows patients to get treatment at home via the Internet while the clinician is at a clinic ([@b29-v4n1-art-10.5195-ijt.2012.6083]). This innovative way to deliver rehabilitation services could be a good way to increase accessibility.

Some telerehabilitation applications have addressed language and speech disorders ([@b11-v4n1-art-10.5195-ijt.2012.6083]; [@b16-v4n1-art-10.5195-ijt.2012.6083]; [@b34-v4n1-art-10.5195-ijt.2012.6083]), mental health ([@b2-v4n1-art-10.5195-ijt.2012.6083]) and physical health such as wounds ([@b14-v4n1-art-10.5195-ijt.2012.6083]; [@b31-v4n1-art-10.5195-ijt.2012.6083]; [@b37-v4n1-art-10.5195-ijt.2012.6083]), orthopedic ([@b1-v4n1-art-10.5195-ijt.2012.6083]; [@b20-v4n1-art-10.5195-ijt.2012.6083]; [@b23-v4n1-art-10.5195-ijt.2012.6083]; [@b35-v4n1-art-10.5195-ijt.2012.6083]; [@b36-v4n1-art-10.5195-ijt.2012.6083]) and neurological conditions ([@b32-v4n1-art-10.5195-ijt.2012.6083]). These studies demonstrated the feasibility of teletreatment. To our knowledge, there is no study on telerehabilitation with patients with COPD. In this context, the main purpose of the study was to explore the feasibility of an in-home telerehabilitation program for people with COPD.

Methods
=======

Design
------

The design was a pre-experimental pilot study with pre/post-tests and no control group. Participants were assessed before the program (T1), and again after the eight-week program (T2). Both assessments were performed by an independent research assistant under the supervision of medical staff.

Sample
------

People with COPD were recruited in a rehabilitation outpatient group and by direct referrals from pneumologists with outpatients who have COPD. For the rehabilitation outpatient group, the first meeting provided information about the purpose of the study and briefly described the participants' role. Patients interested in participating were asked to give their names to the research assistant. On the other hand, pneumologists obtained verbal consent from their patients to be contacted by the research assistant. In both recruitment scenarios, the patient received a call from a member of the research team who gave more information about the study. If the patient was still interested in participating, he/she was invited to sign the consent form.

Inclusion criteria were: 1) forced expiratory volume in one second (FEV1) between 30 and 50% (as indicated in the medical record); 2) no contraindication for physical exercise; 3) sufficient verbal and written understanding of the instructions to participate in a remote treatment and fill out questionnaires; and 4) access to a high speed Internet connection. The only criterion for exclusion was oxygen dependency.

Technological infrastructure for telerehabilitation services
------------------------------------------------------------

Based on experience from two previous studies ([@b3-v4n1-art-10.5195-ijt.2012.6083]; [@b35-v4n1-art-10.5195-ijt.2012.6083]), a telerehabilitation platform was developed and refined. The platform included various components in order to provide a user-friendly experience for both the clinician and the patient at home. While they were similar in many ways, two different systems were used to provide telerehabilitation services: an "in-home" system and a clinician system. The telerehabilitation platform and software interface for both systems are illustrated in [Figure 1](#f1-v4n1-art-10.5195-ijt.2012.6083){ref-type="fig"}.

Components of both systems: A) videoconferencing system, B) LCD screen, C) router and modem connecting to the Internet, D) sensors and external devices, E) clinician computer and screen display.

The core of these systems was the videoconferencing system (Tandberg 550 MXP), which used a h.264 video codec and integrated a pan-tilt-zoom (PTZ) wide angle camera and an omnidirectional microphone. The system was mounted over a 25.5 inch touchscreen computer. The computer was used to display the video received from the other end, but was also used as a sensor display for the patient. Audio was played using external speakers placed on both sides of the screen. Video and audio data were encrypted and transmitted over a high-speed Internet connection, allowing communication using a maximum bandwidth of 512 kbps for both upload and download. The system was also resilient to packet loss and ensured that audio and video were correctly synchronized. The in-home system included a wireless oxymeter sensor. This sensor provided additional information in real time to the clinician, such as oxygen saturation level and heart rate. The bandwidth will vary according to the number and type of sensors included in the setup but is currently very low since data is transmitted at 1 Hz.

The computer installed at home served as a base station for the sensor network and was wirelessly connected to the router. Sensors illustrated in the picture include: inertial measurement units, respiratory belts, pulse oxymeters and instrumented soles.

On the clinician's side, a similar system was used. A software interface (TeRA) running on the clinician's computer provided user-friendly control and monitoring of videoconferencing sessions, control of the cameras, built-in clinical tests, photo and video recording and external sensors and devices support ([@b15-v4n1-art-10.5195-ijt.2012.6083]). The platform was developed to ensure that interactions between clinicians and clients during the telerehabilitation sessions were not impeded by technology but facilitated with user-friendly interfaces. A special effort was made to provide a mouse-based interface to intuitively control, from a unique screen through point-and-click or area zoom, PTZ camera functions at both sites.

Outcome measures
================

Function was measured using aerobic capacity assessed by the standardized six-minute walk test (6MWD) ([@b27-v4n1-art-10.5195-ijt.2012.6083]). This test is frequently used to evaluate the functional capacity of patients with COPD ([@b10-v4n1-art-10.5195-ijt.2012.6083]; [@b27-v4n1-art-10.5195-ijt.2012.6083]). During the test, patient walks around and around on a regular plane surface for six minutes, trying to cross biggest distance; encouragement is given every minute. Heart frequency and oxyhemoglobin saturation were measured before and after the test. The 6MWD test has demonstrated high validity and reliability in assessing changes in functional capacity following pulmonary rehabilitation in patients with chronic obstructive lung disease ([@b28-v4n1-art-10.5195-ijt.2012.6083]).

Quality of life was evaluated with the French version of the Chronic Respiratory Questionnaire (CRQ). The questionnaire has 20 items divided into 4 domains: 1) dyspnea, 2) fatigue, 3) emotional function, and 4) mastery. Each item is rated on a numeric scale from one to seven. A higher score is associated with good quality of life. The CRQ presents very good validity and reliability ([@b7-v4n1-art-10.5195-ijt.2012.6083]). The minimum significant difference is a half point on a 7-point scale ([@b7-v4n1-art-10.5195-ijt.2012.6083]).

Adherence to the program was evaluated by a pen-and-paper journal. Each participant was asked to record in the journal each time he/she did the exercise program, including the time spent on the stationary bike, level of dyspnea, SaO2 (with a probe) and number of repetitions of each strengthening exercise.

Teletreatment: physiotherapy program
------------------------------------

The treatment was a home-based pulmonary telerehabilitation program. The main purpose of the program was to improve muscle and aerobic capacity. The program was divided into four parts: 1) warm-up and stretching, 2) strengthening, 3) cardiorespiratory endurance, and 4) cool-down. The program was based on the institution home pulmonary rehabilitation program and the "Living well with COPD program" developed by the Montreal Chest Institute ([@b8-v4n1-art-10.5195-ijt.2012.6083]).

The cardiorespiratory training was given on a stationary bike and lasted between 10 and 45 minutes depending on the individual's physical condition. After each session, some physiological responses to exercise were measured to be sure that the participant was fine: 1) dyspnea (modified Borg scale) ([@b4-v4n1-art-10.5195-ijt.2012.6083]), 2) heart frequency, and 3) SaO2 (had to be 88% or over) obtained from the probe.

The program was given over an eight-week period. The number of teletreatments decreased gradually to be replaced by unsupervised treatments in order to give and develop the patients' motivation to do the exercises by themselves in the future. The schedule followed was the same for all participants: 1) weeks 1 and 2: three teletreatments, none without supervision; 2) weeks 3, 4 and 5: two teletreatments, one without supervision; 3) weeks 6, 7 and 8: one teletreatment, two without supervision.

Results
=======

### Descriptive statistics of the sample

Three participants were enrolled in this pilot study. The first participant was a man (68 years old), the second was a woman (60 years old) and the last was a man (45 years old). Their FEV1 scores were 42%, 55% and 50%, respectively.

### Locomotor function (walking performance)

In the 6MWD, two of the three participants showed significant improvement (more than 54 meters) while no change was observed for the other. [Figure 3](#f3-v4n1-art-10.5195-ijt.2012.6083){ref-type="fig"} presents the results of the 6MWD for the three participants.

Quality of life
---------------

For all the dimensions of quality of life (dyspnea, fatigue, emotions, mastery), all participants showed a trend towards better quality of life. Results of the MCQ questionnaire are presented in [Figure 4](#f4-v4n1-art-10.5195-ijt.2012.6083){ref-type="fig"}.

Discussion
==========

The objective of this pilot study was to investigate the feasibility of delivering a pulmonary exercise program by telerehabilitation between the patient's home and a clinic for patients with COPD. To our knowledge, this is the first study to illustrate the feasibility of carrying out a complete telerehabilitation program for this population. Our study showed clinically relevant positive changes in locomotor function (walking performance) and quality of life after the intervention.

For the first participant no notable improvement was obtained in locomotor function. This result may be partly because the participant had an exacerbation during the last week of the program. Although he had a pulmonary complication just before the second evaluation, there was no clinically significant decrease in the 6MWD. However, this participant showed a significant clinical improvement in the four domains evaluated for quality of life (dyspnea, fatigue, emotional function and mastery). The second and third participants both showed a significant clinical improvement in locomotor function and in the four domains evaluated for quality of life. These results indicate the clinical relevance of teletreatment with people affected by COPD.

Regarding study limitations, selection bias was probably an issue. Patients who agreed to participate were probably more motivated and willing to explore new types of therapy. To ensure the participants' safety, the level of dyspnea was assessed at different time points during treatment with the modified Borg Scale.

To diminish information bias, the independent assessor evaluated the participants with standardized instruments.

From a technical standpoint, occasional disconnection problems occurred during the program. However, they did not affect the overall clinical experience, even if heart frequency and SaO2 could not be assessed during the program.

Even with the small sample size (n = 3) of this study, it was possible to determine the feasibility of in-home pulmonary rehabilitation teletreatment.

CONCLUSION
==========

Teletreatment seems to be a practical way, both clinically and technically, to dispense rehabilitation services for patients with COPD. Further research is needed with a more powerful design (e.g. randomized controlled trial) to measure the efficacy of this novel way of delivering a pulmonary rehabilitation program through teletreatment.

This research was supported in part by a grant received from the Research Centre on Aging. We would like to thank the study participants.

![Telerehabilitation systems](v4n1-art-10.5195-ijt.2012.6083f1){#f1-v4n1-art-10.5195-ijt.2012.6083}

![6-minute walk test](v4n1-art-10.5195-ijt.2012.6083f3){#f3-v4n1-art-10.5195-ijt.2012.6083}

![Chronic Respiratory Questionnaire scores](v4n1-art-10.5195-ijt.2012.6083f4){#f4-v4n1-art-10.5195-ijt.2012.6083}
